期刊文献+

HBV感染不同免疫状态与PCⅢ、C-Ⅳ表达水平的关系 被引量:1

Study on the expressions of PCⅢ and C-Ⅳ in patients with HBV infection during different immune status
暂未订购
导出
摘要 目的探讨HBV感染不同免疫状态(免疫耐受、免疫清除、免疫不全状态)者Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(C-Ⅳ)表达水平的差异及临床意义。方法将60例HBV感染后不同疾病阶段者分为免疫耐受状态(免疫耐受组)、免疫清除状态(免疫清除组)和免疫不全状态(免疫不全组)各20例;另选20例健康体检者作为对照组。收集研究对象静脉血,应用电化学发光法检测PCⅢ、C-Ⅳ表达水平。结果 PCⅢ水平:免疫清除组、免疫不全组高于对照组(z值分别为-5.041、-4.095,P均<0.05),免疫清除、免疫不全组与免疫耐受组比较差别有统计学意义(z值分别为-5.356、-4.599,P均<0.05)。C-Ⅳ水平:免疫清除组、免疫不全组与对照组比较差异有统计学意义(z值分别为-3.273、-4.166,P均<0.05),免疫清除、免疫不全组与免疫耐受组差别有统计学意义(z值分别为-2.570、-2.732,P均<0.05)。结论慢性HBV感染者血清PCⅢ、C-Ⅳ表达水平与机体的免疫调节状态密切相关,且对肝纤维化的诊断有重要的临床意义。 Objective To study the expression and significance of the serum levels of PC m and C-IV in patients with I-IBV infection during different immune status. Methods The patients of HBV infection were divided into three groups with immune tolerance, immune clearance, immunodeficiency. Serum samples were collected from 20 cases of immune tolerance, 20 cases of immune clearance, 20 cases of immunodeficiency and 20 cases of normal control. Serum levels of PC Ⅲ and C-Ⅳ were measured by the electrochemical luminescence method. Results The serum levels of PC Ⅲ in the immune clearance and immunodeficiency group were higher than those of the normal control group(z = -5. 041, -4. 095, all P 〈 0.05 ). And the serum expression levels of PC Ⅲ of immune clearance group and immunodeficiency group were higher than those of immune tolerance group respectively (z = -5. 356, -4. 599, all P 〈 0.05 ). The serum levels of C-IV in immune clearance group and immunodeficiency group had significant difference with normal control group respectively(z= -3. 273, -4. 166, all P 〈 0.05 ). The serum expression levels of C-IV in immune clearance and immunodeficiency group were high er than those in immune tolerance group respectively (z = - 2. 570, - 2. 752, all P 〈 0.05 ). Conclusion Serum levels of PCⅢ, C-Ⅳ are closely related with the immune status in patients with chronic HBV infection. The expression levels of PC Ill, C-IV have important clinical significance to the diagnosis of hepatic fibrosis.
出处 《山东医药》 CAS 2012年第13期10-12,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30760294) 广西科学研究与技术开发计划项目(桂科攻10124001B)
关键词 肝炎 乙型 慢性 免疫状态 前胶原 hepatitis B, chronic immune status procollagen
  • 相关文献

参考文献10

  • 1Shiha G. Serum hyaluronic acid : a promising marker of hepatic fi- brosis in chronic hepatitis B [ J ]. Saudi J Gastroenterol, 2008,14 (4) :161-162.
  • 2Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fi- brosis : clinical translation of molecular pathogenesis or based on liv- er-dependent malfunction tests [ J ]. Clin Chim Acta, 2007,381 (7) :107-113.
  • 3Bedossa P, Dargere D, Paradis V. Sampling variability of liver fi- brosis in chronic hepatitis C [ J ]. Hepatology, 2003,38 ( 6 ) : 1449- 1457.
  • 4Veidal SS, Bay-Jensen AC, Tougas G, et al. Serum markers of liver fibrosis : combining the BIPED classification and the neo-epitopc ap- proach in the development of new biomarkers [ J ]. Dis Markers, 2010,28 ( 13 ) : 15-28.
  • 5Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infec- tion[ J]. Immunol Cell Biol, 2007,85 ( 1 ) : 16-23.
  • 6中华医学会肝病学分会、感染病学分会.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891.
  • 7杨丽莎.乙型肝炎病毒感染不同免疫状态证候的研究思路[J].中国药物与临床,2008,8(9):682-683. 被引量:13
  • 8Chan HL, Jia JD. Chronic hepatitis B in Asia-new insights from the past decade [ J ]. J Gastroenterol Hepatol, 2011,26 ( Suppl 1 ) : 131 - 137.
  • 9李文全,曹春晓,杨琦,姚玲.血清肝纤维化指标在慢性肝病中的临床分析[J].中国当代医药,2009,16(14):50-51. 被引量:3
  • 10胡兴荣,崔显念,胡启托,陈军.血清肝纤维化指标与慢性肝炎肝纤维化程度的相关性[J].世界华人消化杂志,2010,18(14):1501-1503. 被引量:57

二级参考文献30

共引文献1991

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部